Dual Versus Triple Antithrombotic Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation: An Updated Meta-Analysis

被引：2
|
作者：
Goel, Sunny [1 ]
Pasam, Ravi Teja [1 ]
Sharma, Abhishek [2 ]
Gidwani, Umesh [3 ]
机构：
[1] Maimonides Hosp, Dept Cardiol, Brooklyn, NY 11219 USA
[2] Rush Univ, Med Ctr, Dept Cardiol, Chicago, IL 60612 USA
[3] Icahn Sch Med Mt Sinai, Dept Cardiol, New York, NY 10029 USA
来源：
CARDIOVASCULAR REVASCULARIZATION MEDICINE | 2020年 / 21卷 / 02期
关键词：
Atrial fibrillation; acute coronary syndrome; Percutaneous coronary intervention; Dual antithrombotic therapy; Triple antithrombotic therapy;
D O I：
10.1016/j.carrev.2019.08.015
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：239 / 241
页数：3
相关论文
共 50 条
  • [41] Antithrombotic Therapy During and After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation
    Verheugt, Freek W. A.
    [J]. CIRCULATION, 2013, 128 (18) : 2058 - 2061
  • [42] From WOEST to AUGUSTUS: a review of safety and efficacy of triple versus dual antithrombotic regimens in patients with atrial fibrillation requiring percutaneous coronary intervention for acute coronary syndrome
    Jones, David W.
    Minhas, Sheharyar
    Fierro, Joseph J.
    Ardeshna, Devarshi
    Rawal, Aranyak
    Cave, Brandon
    Shah, Samarth P.
    Khouzam, Ruth N.
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (17)
  • [43] Comparison of triple antithrombotic therapy and dual antiplatelet therapy for patients with atrial fibrillation after percutaneous coronary stenting
    Fan, Xiaoying
    Zhang, Yao
    [J]. PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 29 (05) : 1769 - 1773
  • [44] Dual and triple antithrombotic pharmacotherapy inpatientsn patients with coronary heart disease complicated with atrial fibrillation after percutaneous coronary intervention
    Tan, Jiaoyan
    Si, Liangyi
    Yang, Xiaorong
    Yue, Jia
    [J]. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2022, 21 (12) : 2701 - 2708
  • [45] Reply to: Dual vs. triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention
    Golwala, Harsh
    Cannon, Christopher P.
    Bhatt, Deepak L.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 (02) : 218 - 219
  • [46] TRIPLE VERSUS DUAL ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
    Hu, Bin
    Zhou, Yujie
    Liu, Yuyang
    Shi, Dongmei
    Zhao, Yingxin
    Jia, Dean
    [J]. HEART, 2010, 96 : A107 - A107
  • [47] Optimal antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: A systemic review and meta-analysis
    Li, Jing-Xiu
    Li, Yang
    Yan, Shu-Jun
    Han, Bai-He
    Song, Zhao-Yan
    Song, Wei
    Liu, Shi-Hao
    Guo, Ji-Wei
    Yin, Shuo
    Chen, Ye-Ping
    Xia, De-Jun
    Li, Xin
    Li, Xue-Qi
    Jin, En-Ze
    [J]. BIOMEDICAL REPORTS, 2018, 8 (02) : 138 - 147
  • [48] Comparative Effectiveness and Safety of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome or Percutaneous Coronary Intervention
    Wang, Yueh-Hsin
    Kao, Hsien-Li
    Wang, Chi-Chuan
    Lin, Shin-Yi
    Lin, Fang-Ju
    [J]. ACTA CARDIOLOGICA SINICA, 2019, 35 (05) : 508 - 521
  • [49] Antithrombotic therapy after acute coronary syndrome or percutaneous coronary intervention
    Zado, Erica S.
    [J]. HEART RHYTHM, 2022, 19 (05)
  • [50] Double antithrombotic therapy for prevention of bleeding and ischemic events after percutaneous coronary intervention in patients with atrial fibrillation A meta-analysis
    Qiu, Mei
    Liu, Shu-Yan
    Zhou, Hai-Rong
    [J]. MEDICINE, 2021, 100 (01) : E24188
12345